ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer (FORTIS-C)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00706862
Recruitment Status : Unknown
Verified March 2012 by Agennix.
Recruitment status was:  Recruiting
First Posted : June 30, 2008
Last Update Posted : March 15, 2012
Sponsor:
Information provided by (Responsible Party):
Agennix

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2015
  Estimated Study Completion Date : March 2016